Intrinsiqs

Is Ligand Pharmaceuticals Incorporated overvalued?

Ligand Pharmaceuticals Incorporated (LGND) looks overvalued — trading about 32% above its fair value.

Overvalued
Current price $288.82 Fair value $197.56
Price
$288.82
Fair value
$197.56
Current P/E
34.6
Normal P/E
23.7
Market cap
$5.79B
Dividend yield
0.2%
Return on equity
20.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares LGND's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.